Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden ...

The interim topline results demonstrate the potential of this investigational epcoritamab combination regimen to treat relapsed or refractory follicular lymphoma patients,” said Jan van de ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

These are follicular cysts and corpus luteum cysts. During the menstrual cycle, an egg grows in a follicle sac. This sac is located inside the ovaries. In most cases, the follicle breaks open and ...

Neutrophil-associated scarring alopecias include folliculitis decalvans, perifolliculitis capitis abscendens et suffodiens (of Hoffman), and acne keloidalis nuchae. Although the exact etiology is ...

Follicular Technologies Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 10.0 ...

Epizyme has scored an important FDA win after the regulator approved its Tazverik (tazemetostat) in follicular lymphoma. Tazverik is already approved in patients with epithelioid sarcoma, a rare ...